| Catalog Number |
YR1155 |
|
| Product Name |
Research Grade Obinutuzumab |
|
| Clonity |
Monoclonal |
|
| Alias |
GA101, RG7159, RO5072759 |
|
| Size |
1mg, 5mg |
|
| Concentration |
1mg/ml |
|
| Isotype |
IgG1 Kappa |
|
| Host |
Mouse |
|
| CAS Number |
949142-50-1 |
|
| Applications |
IP, IF, FuncS, FC, Neut, ELISA, ICC |
|
| Source |
CHO Cells |
|
| Purity |
≥95% as determined by SDS-PAGE |
|
| Buffer |
Supplied in PBS, PH7.5 |
|
| Molecular Weight |
150000.00 Da |
|
| Background |
Obinutuzumab (called afutuzumab until 2009) is a humanized anti-CD20
monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment. |
|
| Storage |
Stored at -20℃ to -80℃ . |
|
| Shipping Condition |
Shipped on ice packs. |
|
中文
